Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microchimerism in the human brain, quantitative assessment and single nuclei profiling establish cell types and diversity.

bioRxiv : the preprint server for biology·2026
Same author

Recommendations for Radiation Treatment in Pediatric Patients With Metastatic Rhabdomyosarcoma: Expert Consensus From the International Soft Tissue SaRcoma ConsorTium (INSTRuCT).

Practical radiation oncology·2026
Same author

No Difference in Posterior Tibial Slope Comparing Patients With and Without Delayed Anterior Cruciate Ligament Tear After Tibial Spine Fracture: A Multicenter Study.

Journal of the Pediatric Orthopaedic Society of North America·2026
Same author

Childhood Cancer Data Initiative Participant Index: Mapping Pediatric Cancer Data to Facilitate Cross-Study Integrated Analysis.

JCO clinical cancer informatics·2026
Same author

FDA approvals for pediatric cancer indications using children's oncology group associated trials data.

Journal of the National Cancer Institute·2026
Same author

Complications Leading to Reoperation After Pediatric Tibial Spine Fracture Fixation.

Orthopaedic journal of sports medicine·2026

Related Experiment Video

Updated: Jun 13, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Malignant progression in two children with multiple osteochondromas.

Gregory A Schmale1, Douglas S Hawkins, Joe Rutledge

  • 1Department of Orthopaedics and Sports Medicine, School of Medicine, University of Washington, Seattle, WA 98195, USA.

Sarcoma
|May 15, 2010
PubMed
Summary
This summary is machine-generated.

Multiple Osteochondromas (MO) rarely leads to secondary chondrosarcoma in children. This study details two pediatric MO cases with aggressive lesions, successfully treated with allograft reconstruction and showing no recurrence.

More Related Videos

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Related Experiment Videos

Last Updated: Jun 13, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Area of Science:

  • Orthopedics
  • Pediatric Oncology
  • Skeletal Dysplasias

Background:

  • Multiple Osteochondromas (MO) is a rare genetic disorder characterized by benign bony growths.
  • Malignant transformation into secondary chondrosarcoma is infrequent, especially in pediatric patients.
  • Diagnosing low-grade cartilage tumors requires integrating clinical, radiographic, and histopathological data.

Observation:

  • Two skeletally immature patients with MO presented with rapidly enlarging, aggressive bone lesions.
  • These lesions were radiographically suspicious for malignant transformation.
  • Both patients underwent surgical intervention with allograft reconstruction.

Findings:

  • The aggressive lesions in both pediatric MO patients were confirmed as malignant transformation.
  • Allograft reconstruction was performed for the affected skeletal sites.
  • A minimum follow-up of four years showed no evidence of recurrence or metastatic disease.

Implications:

  • This case series highlights the importance of vigilance for malignant transformation in pediatric MO.
  • Prompt diagnosis and surgical management, including allograft reconstruction, can lead to favorable outcomes.
  • Further research into early detection and treatment strategies for secondary chondrosarcoma in MO is warranted.